Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05169528
Other study ID # CIRB Ref No.:2020/2063
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date June 30, 2021

Study information

Verified date December 2021
Source Changi General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cancer prehabilitation typically involves multiple pre-op visits. The investigators aim to assess the impact of their novel model, a "one-stop "service by a small, "levelled-up" core team on newly diagnosed colorectal cancer patients planned for surgery.


Description:

Objective Cancer prehabilitation typically involves multiple pre-op visits. The investigators aim to assess the impact of their novel model, a "one-stop "service by a small, "levelled-up" core team on newly diagnosed colorectal cancer patients planned for surgery. Design This is a before-after trial in a tertiary public hospital in Singapore, involving all newly diagnosed colorectal cancer patients planned for surgery who are referred to the Cancer Prehabilitation Program. The primary outcome measure is the 6-minute-walk-test. Others include physical, psychological, quality-of-life and post-operative measures, and patient-satisfaction-surveys, taken at baseline, pre-operatively (post-prehabilitation), and 3-months-post-operatively. Keywords: Colorectal; Cancer Prehabilitation; Novel; Model of Care


Recruitment information / eligibility

Status Completed
Enrollment 59
Est. completion date June 30, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender All
Age group 21 Years to 99 Years
Eligibility Inclusion Criteria: 1. All newly diagnosed colorectal cancer patients planned for surgery in Changi General Hospital, Singapore Exclusion Criteria: 1. Patients' refusal to participate

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Colorectal Cancer Prehabilitation Programme
Assessment and Interventions involving the Prehabilitative domains of medical optimisation, exercise prescription, nutrition and mental health optimisation

Locations

Country Name City State
Singapore Changi General Hospital Singapore

Sponsors (1)

Lead Sponsor Collaborator
Changi General Hospital

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary 6-minute-walk-test Distance walked in 6 minutes under standardised conditions Baseline
Primary 6-minute-walk-test Distance walked in 6 minutes under standardised conditions Pre-Operatively (after prehabilitation)
Primary 6-minute-walk-test Distance walked in 6 minutes under standardised conditions Post-Operatively (3 months)
Secondary 30-second-sit-to-stand-test Number of repetitions of sit-to-stand within 30 seconds Baseline
Secondary 30-second-sit-to-stand-test Number of repetitions of sit-to-stand within 30 seconds Pre-Operatively (after prehabilitation)
Secondary 30-second-sit-to-stand-test Number of repetitions of sit-to-stand within 30 seconds Post-Operatively (3 months)
Secondary Hospital Anxiety and Depression Scale Divided into Anxiety (0-21 points) and Depression scale (0-21 points), the higher the worser Baseline
Secondary Hospital Anxiety and Depression Scale Divided into Anxiety (0-21 points) and Depression scale (0-21 points), the higher the worser Pre-Operatively (after prehabilitation)
Secondary Hospital Anxiety and Depression Scale Divided into Anxiety (0-21 points) and Depression scale (0-21 points), the higher the worser Post-Operatively (3 months)
Secondary EuroQol- 5 Dimension Health Score (visual analogue scale from 0-100), the higher the better Baseline
Secondary EuroQol- 5 Dimension Health Score (visual analogue scale from 0-100), the higher the better Post-Operatively (3 months)
Secondary Post-Operative Hospital Length of Stay Post-Operative Hospital Length of Stay From Date of Admission for Surgery till Date of Discharge, assessed up to 100 weeks
Secondary 30-Day Post-Operative Major Complications 30-Day Post-Operative Major Complications From Surgery till 30 Days Post-op
Secondary 30-Day Post-Operative Readmission Rates 30-Day Post-Operative Readmission Rates From Surgery till 30 Days Post-op
Secondary 30-Day Post-Operative Mortality 30-Day Post-Operative Mortality From Surgery till 30 Days Post-op
Secondary Patient Satisfaction Survey Patient Satisfaction Survey Pre-Operatively (after prehabilitation)
Secondary Patient Satisfaction Survey Patient Satisfaction Survey Post-Operatively (3 months)
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A